The AXSANA trial, MagTotal and ideal tracer injection sites – highlights from ESSO 41

The AXSANA trial, MagTotal and ideal tracer injection sites – highlights from ESSO 41

28 minute watch

At this year’s European Society of Surgical Oncology (ESSO), we brought some of the finest minds from Europe and Africa together to discuss the latest advances in axilla management featuring Magseed® and Magtrace®.

Watch as our host, Mr Peter Barry from the UK’s Royal Marsden Hospital, is joined by Dr Andreas Karakatsanis, Prof. Thorsten Kuehn, Dr Séverine Alran and Dr Carol Benn, to discuss (among much more):

  • The latest on the cross-European AXSANA study, analysing the effectiveness of Targeted Axillary Dissection across 3,000+ patients.
  • Using Magseed® and Magtrace® in combination to great effect, as demonstrated in the MagTotal study.
  • How to inject a lymphatic tracer – particularly Magtrace® – to achieve the best mapping effects.